Rules for Marketing on Psychable*

Below are Psychable’s rules for marketing for legal psychedelic-assisted therapy on our platform.

Practitioners who use Psychable may offer certain services for individuals interested in psychedelic-assisted or alternative healing modalities (collectively, the “Seekers”). Practitioners may market certain services for seekers without violating the Controlled Substances Act (the “CSA”). Generally, the CSA prohibits a person from placing an advertisement knowing that it has the purpose of seeking or offering to receive, buy, or distribute a Schedule I controlled substance. However, advertisement does not include materials that advocate the use of a similar material, which advocates a position or practice, and does not attempt to propose or facilitate an actual transaction in a Schedule I controlled substance.

Schedule I controlled substances include, but are not limited to:

• DMT (an active ingredient in ayahuasca)
• LSD (“acid”)
• Psilocybin (“magic mushrooms”)
• Ibogaine
• 5-Meo-DMT
• Mescaline
• MDMA (“molly” or “ecstasy”)
• Cannabis

What does this mean for advertising content published by practitioners on Psychable?

• Generally, practitioners MAY advertise the following on Psychable’s platform:
  1. services that do not involve the use of, propose or facilitate a transaction in a Schedule I controlled substance in violation of the CSA. For example, services may include integration or after care support that do not directly involve controlled substances or a transaction thereof of any kind.
  2. services involving the use of ketamine, subject to any applicable medical licensing requirements and/or DEA qualifications.
  3. services that involve only uncontrolled or unscheduled substances, such as Kambo or Rapé/mapacho.
  4. services in another country where the use of certain Schedule I substances is permitted in that country,** and does not in any way promote or facilitate an illegal use or transaction involving, related to, or in connection with a Schedule I substance in the United States.

• Generally, practitioners MAY NOT advertise the following on the Psychable’s platform :
  1. any services that directly involves the use of  a Schedule I substance without any federal exemption or authorization (e.g., FDA clinical trials, DEA approved research)
  2. any Schedule I substances for sale, purchase, distribution, or in any manner of transacting
  3. anything that would aid or abet prohibited services referenced above in sections (a) and (b).
  4. any medical services they are not licensed to provide.
• Psychable prohibits any content that promotes, endorses, or facilitates a transaction, including but not limited to the sale, purchase, or distribution of a Schedule I controlled substance. Any such content violates Psychable’s Terms of Use and a violation will result in removal of the content, termination of the applicable account(s), or any other appropriate action as enumerated in our Terms of Use or as required by law.

Will sitters be able to advertise on Psychable?

• Some individuals may use Psychable to offer services whereby they remain sober and provide a supportive presence to hold space for the Seekers (“Sitters”).
• Generally, Sitters MAY advertise the following on Psychable’s platform:
  1. services that do not involve the use of, propose or facilitate a transaction in a Schedule I controlled substance in violation of CSA. For example, services may include integration, after care support that do not directly involve controlled substances or a transaction thereof of any kind.
  2. services involving the use of ketamine, subject to any applicable medical licensing requirements and/or DEA qualifications.
  3. services that involve only uncontrolled or unscheduled substances, such as Kambo or Rapé/mapacho.
  4. services in another country where the use of certain Schedule I substances is permitted in that country,** and does not in any way promote or facilitate an illegal use or transaction involving, related to, or in connection with a Schedule I substance in the United States.
  5. provision of  support services for harm reduction purposes that are not in violation of Controlled Substances Act. While Sitters may advertise such support services, they do so at their own risk because such services, while not directly involving a transaction in Schedule I substances, are closely connected to the prohibited use of Schedule I controlled substances.

• Generally, Sitters MAY NOT advertise the following on Psychable’s platform:
  1. any services that directly involves the use of a Schedule I substance without any federal exemption or authorization (e.g., FDA clinical trials, DEA approved research)
  2. any Schedule I substances for sale, purchase, distribution, or in any manner of transacting
  3. anything that would aid or abet prohibited services referenced above in sections (a) and (b).
  4. any medical services they are not licensed to provide.

* Disclaimer: This article is for informational purposes only and for the purpose of explaining Psychable’s conduct requirements for marketing. This article is not for the purpose of providing legal advice. You should not act upon any such information without first seeking qualified professional counsel on your specific matter. Contact an attorney to obtain advice with respect to your particular issue or problem.

* * Disclaimer: This article only provides information about marketing on Psychable’s platform with respect to services in the United States.